The Latest Cardiac and Vascular News
DENVER, Oct. 30, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced that patients who underwent minimally-invasive implantation with a XIENCE coronary stent for left-main coronary artery disease had the same long-lasting health outcomes at three years but felt better more quickly than patients who underwent open-heart surgery. The data were presented during […]
Studies over the past two decades have shown that transradial access for PTCA interventions to have an advantage over transfemoral. Specifically, that access-site and bleeding complications are nearly eliminated. This was an important advantage because although there have been advances in interventional techniques, antithrombotic therapy, and closure devices, bleeding complications […]
RESEARCH TRIANGLE PARK, N.C. and TORONTO, Oct. 30, 2017 /PRNewswire/ — Analytics 4 Life, a digital health company applying the power of artificial intelligence to develop solutions that improve existing care pathways, today announced it will be presenting new clinical data on the Company’s ongoing Coronary Artery Disease Learning and Algorithm Development (CADLAD) study at […]
WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (NYSE American:CVRS), a leading developer of precision vascular robotics, announced today that it will be participating in the Transcatheter Cardiovascular Therapeutics (TCT) 2017 Conference to be held October 29 – November 2 in Denver, CO. Robotic-assisted percutaneous coronary intervention (PCI) will be featured throughout the conference, […]
MOUNTAIN VIEW, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) — Vascular Dynamics, a privately held medical device company developing novel solutions for the treatment of hypertension, will present updated interim results of the company’s first-in-human trial of its MobiusHD® implant today at the TCT conference in Denver. The data showed an average reduction […]
PALO ALTO, Calif., Oct. 30, 2017 /PRNewswire-USNewswire/ — ReCor Medical announced progress milestones in the study of its Paradise® Renal Denervation System as a potential treatment for hypertension, including the 1000th consented and the 150th randomized subjects in the RADIANCE-HTN study, and publication of a study design review in the American Heart […]
ABBOTT PARK, Ill., Oct. 30, 2017 /PRNewswire/ — Abbott today announced it received CE Mark for XIENCE Sierra, the newest generation of the company’s gold-standard XIENCE everolimus-eluting coronary stent system. CE Mark allows sale of the device in the European Union and other countries that recognize CE Mark. Advances in this generation […]
PARIS–(BUSINESS WIRE)– HighLife, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the closing of a €12.3 million investment round led by Sofinnova Partners which becomes the main investor in the company. HighLife had previously secured financing from […]
KFAR SABA, Israel, Oct. 27, 2017 /PRNewswire/ — CathWorks Ltd., a leader in the development of non-invasive Fractional Flow Reserve (FFR) measurements for guiding coronary interventions, announced today the appointment of James M. Corbett as its Chief Executive Officer. Corbett, an industry veteran with broad experience in global commercialization, has served as President, Boston Scientific International, […]
NETANYA, Israel, October 26, 2017 /PRNewswire/ — Nitiloop, a medical device company dedicated to the development of Cardiovascular and peripheral microcatheters for complex lesions, received FDA clearance for its new Nova Cross™ Extreme and Nova Cross™ BTK. These dedicated microcatheters are joining the Nova Cross™ product family combining innovative low profile microcatheter technology with uniquely designed Nitinol scaffold providing […]
